No judgment. No stigma.
Round-the-clock care from people that get you
Treatment that fits into your life, not the other way around
Private, affordable, and fast
Most pregnant + postpartum patients with opioid use disorder face stigma, misinformation, and fragmented care. We're changing that.
Ophelia Maternal Care is a dedicated clinical program for pregnant and postpartum patients managing opioid use disorder (OUD).
✓ Fully virtual
✓ Covered by Medicaid
✓ Advocacy support
✓ Care through the full postpartum period, including postpartum psychiatric syndromes
THE CLINICAL REALITY
Opioid use disorder during pregnancy is one of the most dangerous gaps in healthcare
Pregnant patients with opioid use disorder face a system that was never built for them. The clinical consensus is unambiguous: medications for opioid use disorder (MOUD), specifically buprenorphine, significantly reduces maternal overdose, preterm birth, and neonatal complications, including Neonatal Opioid Withdrawal Syndrome (NOWS). Yet most pregnant patients with OUD go untreated, because access, stigma, and fragmented care keep them from the treatment they need.
Ophelia Maternal Care was built to close that gap: a specialized clinical team, ACOG-based protocols for medication management during pregnancy, and a fully virtual model that removes the barriers keeping patients from care.
THE FINANCIAL CASE
Expanding treatment for opioid use disorder in pregnancy improves outcomes and reduces avoidable costs
For payors and MCOs managing pregnant patients with OUD, untreated opioid use disorder generates two compounding cost categories: the acute pregnancy itself, and the downstream costs that follow, including Neonatal Opioid Withdrawal Syndrome (NOWS)-related NICU admissions that can exceed tens of thousands of dollars per case. Ophelia's outcomes data, drawn from a broad Medicaid population, shows measurable reductions across every major cost driver for patients receiving medication treatment.
PROGRAM OUTCOMES
Ophelia Maternal Care data speaks for itself
100%
Of pregnant patients screen positive for buprenorphine and 0% for opioids
88%
of patients in program 30+ days have a BARC-10 score associated with long-term remission
100%
of new pregnant patients remain in care today
How we compare
Ophelia Maternal Care vs. traditional opioid use disorder treatment programs for pregnant patients
ACCESS MODEL
Ophelia Maternal Care: 100% virtual, 7 days a week
Traditional OUD Program: In-person, geographic radius required
PREGNANCY PROTOCOLS
Ophelia Maternal Care: ACOG-based pregnancy-specific protocols, required for all clinicians
Traditional OUD Program: General OUD protocols adapted for pregnant patients
CLINICAL STAFFING
Ophelia Maternal Care: Women's Health NPs (WHNPs) on staff
Traditional OUD Program: General prescribers
POSTPARTUM CARE
Ophelia Maternal Care: Full postpartum continuum: PPD screening, birth control planning, lactation support
Traditional OUD Program: Often ends at delivery
HEDIS PERFORMANCE
Ophelia Maternal Care: 75.5% IET, 62.2% POD — more than double national averages
Traditional OUD Program: Industry avg: 32% IET, 26% POD (Medicaid)
REFERRAL PATHWAY
Ophelia Maternal Care: Custom referral link per health plan. Welcome call same day. Monthly partner report.
Traditional OUD Program: Phone call, fax, or complex intake process
SDOH SUPPORT
Ophelia Maternal Care: 50% of maternity patients have active SDOH challenges; screened and managed in-program
Traditional OUD Program: Limited or referred out
BILLING MODEL
Ophelia Maternal Care: Simple PMPM structure. Standard model + maternity program covered. No separate billing.
Traditional OUD Program: Fee-for-service, visit-based
The return on covered MOUD treatment is significant and measurable
70%
Reduction in total cost of care while in treatment
72%
Reduction in ED visits
95%
Reduction in inpatient mental health costs
Data are from a single Medicaid MCO in New York, including over 1,000 Ophelia patients from 2021-2023
Connected care, for you and your patients
If you're an OB, midwife, or clinical partner looking to connect pregnant patients with specialized opioid use disorder treatment, or a Managed Care Organization (MCO) or Medicaid agency evaluating solutions for opioid use disorder in pregnancy, reach out.